Antibiotic Prophylaxis in Gynecologic Laparoscopy

Antibiotic Prophylaxis in Gynecologic Laparoscopy

Laparoscopy is a surgical procedure indicated for most gynecological pathologies and presents numerous advantages over laparotomy, among them lower rates of surgical site infection and less comorbidity feverish. Despite this, the use of antibiotic prophylaxis is widely accepted and performed by most gynecologists. However, there isn't literature evidence to support the routine use of antibiotics in the prophylaxis of wound infection on laparoscopic pelvic surgery .Therefore, this study will evaluate the need for the use of antibiotic prophylaxis in gynecological laparoscopies not including opening hollow viscera.

It is a clinical, prospective, double-blind, randomized study. 114 women with gynecologic disease, in which there is indication of laparoscopic surgical approach, will be consecutively select. These women will be allocated in two arms, control and study, where control group will use placebo and study will receive intravenous cephazolin. These patients will be followed for 30 days according to Centers for Disease Control and Prevention criteria.

Inclusion Criteria:

• patients with gynecologic disease, undergoing gynecologic laparoscopy without opening hollow viscera.

Exclusion Criteria:

• body mass index over 30 Kg/m2
• smoking
• diabetes type I or II with glycated hemoglobin exceeding 6.5%
• patients who are at surgical risk classification of the American Society of Anesthesiologists(ASA) as ASA III or higher
• refusal to participate
• postoperative antibiotic therapy for another indication clinical complication